Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus
Norikazu Toi, Masaaki Inaba, Masafumi Kurajoh, et al.
Journal of Clinical & Translational Endocrinology (2018) Vol. 15, pp. 37-44
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
Fei Peng, Xin Li, Fang Xiao, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 6, pp. 471-482
Open Access | Times Cited: 43
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Dietary total antioxidant capacity and its association with sleep, stress, anxiety, and depression score: A cross-sectional study among diabetic women
Elnaz Daneshzad, Seyed Ali Keshavarz, Mostafa Qorbani, et al.
Clinical Nutrition ESPEN (2020) Vol. 37, pp. 187-194
Closed Access | Times Cited: 62
Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis
Anitra D.M. Koopman, Joline W. J. Beulens, Tine Dijkstra, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 3, pp. 614-643
Open Access | Times Cited: 56
Sleep interventions and glucose metabolism: systematic review and meta-analysis
Vallari Kothari, Zulma Cardona, Naricha Chirakalwasan, et al.
Sleep Medicine (2020) Vol. 78, pp. 24-35
Closed Access | Times Cited: 51
Connecting insufficient sleep and insomnia with metabolic dysfunction
Daisy Duan, Lenise Jihe Kim, Jonathan C. Jun, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1519, Iss. 1, pp. 94-117
Open Access | Times Cited: 37
The potential role of pancreatic γ-aminobutyric acid (GABA) in diabetes mellitus: A critical reappraisal
Hayder M. Al‐kuraishy, NawarR Hussian, MarwaS Al-Naimi, et al.
International Journal of Preventive Medicine (2021) Vol. 12, Iss. 1, pp. 19-19
Open Access | Times Cited: 34
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Andrew Hogyu Han, Caroline R. Burroughs, Evan P. Falgoust, et al.
Health psychology research (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 13
Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Research Progress on Insomnia and OSA in Patients with Type 2 Diabetes Mellitus
靖威 郑
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1145-1154
Closed Access
Diet and Physical Activity as Determinants of Continuously Measured Glucose Levels in Persons at High Risk of Type 2 Diabetes
Su Hyun Park, Jiali Yao, Xin Hui Chua, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 366-366
Open Access | Times Cited: 13
Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
Atsushi Takahashi, Yukio Anzai, Masahito Kuroda, et al.
BMJ Open (2020) Vol. 10, Iss. 10, pp. e039947-e039947
Open Access | Times Cited: 19
Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia
Fukumi Yoshikawa, Fumika Shigiyama, Yukio Ando, et al.
Diabetes Research and Clinical Practice (2020) Vol. 169, pp. 108412-108412
Closed Access | Times Cited: 16
Disturbed sleep quality and architecture in adolescents with type 1 diabetes mellitus: Relation to glycemic control, vascular complications and insulin sensitivity
Abeer A. Abdelmaksoud, Nouran Yousef Salah, Zeinab Ali, et al.
Diabetes Research and Clinical Practice (2021) Vol. 174, pp. 108774-108774
Closed Access | Times Cited: 15
Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions
Hamza O. Dhafar, Ahmed S. BaHammam
Metabolites (2022) Vol. 12, Iss. 11, pp. 1120-1120
Open Access | Times Cited: 10
Relationship of suboptimal and disordered sleep with cardiovascular disease and its risk factors – a narrative review
Benjamin Wipper, Lukas Mayer‐Suess, Matteo Cesari, et al.
Neuroepidemiology (2024), pp. 1-17
Closed Access | Times Cited: 1
Can treatment of obesity reduce depression or vice versa?
Stephanie L. Borgland
Journal of Psychiatry and Neuroscience (2021) Vol. 46, Iss. 2, pp. E313-E318
Open Access | Times Cited: 10
Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice
Kanta Kon, Hiroshi Tsuneki, Hisakatsu Ito, et al.
Journal of Endocrinology (2019) Vol. 243, Iss. 1, pp. 59-72
Open Access | Times Cited: 7
Clinical Spectrum and Trajectory of Innovative Therapeutic Interventions for Insomnia: A Perspective
Yun-Jo Lo, Viraj Krishna Mishra, Hung-Yao Lo, et al.
Aging and Disease (2022)
Open Access | Times Cited: 4
The orphan G protein-coupled receptor, GPR139, is expressed in the hypothalamus and is involved in the regulation of body mass, blood glucose, and insulin
Pedro Augusto Silva Nogueira, Alexandre Moura‐Assis, Ariane Maria Zanesco, et al.
Neuroscience Letters (2022) Vol. 792, pp. 136955-136955
Closed Access | Times Cited: 3
The association between glycaemic variability and sleep quality and quantity in adults with type 1 and type 2 diabetes: A systematic review
Cecilia T. Pham, Aleena S. Ali, Leonid Churilov, et al.
Diabetic Medicine (2024)
Closed Access
The negative impact of sleep disorders on working memory may be mediated by changes in carbohydrate metabolism
Yu. V. Ukraintseva, Krystsina Liaukovich
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 5, pp. 11-11
Closed Access | Times Cited: 2
Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice
Hiroshi Tsuneki, Masanori Sugiyama, Kiyofumi Sato, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176190-176190
Open Access
Page 1 - Next Page

Scroll to top